Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
Top Cited Papers
- 29 April 2019
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 37 (24), 3167-3178
- https://doi.org/10.1016/j.vaccine.2019.04.055
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31870919)
- Natural Science Foundation of Liaoning Province (20180550597)
- Fundamental Research Funds for the Central Universities (DUT17RC(3)021)
This publication has 108 references indexed in Scilit:
- Mechanisms of Action of AdjuvantsFrontiers in Immunology, 2013
- Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitroImmunology Letters, 2012
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunityVaccine, 2011
- H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell ResponsesJournal of Clinical Immunology, 2010
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Saponins as cytotoxic agents: a reviewPhytochemistry Reviews, 2010
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNAImmunity, 2009
- The Nlrp3 inflammasome is critical for aluminium hydroxide‐mediated IL‐1β secretion but dispensable for adjuvant activityEuropean Journal of Immunology, 2008
- Systemic but not mucosal immunity induced by AVA prevents inhalational anthraxMicrobes and Infection, 2007
- A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patientsProceedings of the National Academy of Sciences of the United States of America, 2007